Compare First Trust NASDAQ 100 Technology Index Fund (QTEC) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
First Trust NASDAQ 100 Technology Index Fund vs Tempus AI — how do they compare? First Trust NASDAQ 100 Technology Index Fund trades at $331.55 (market cap $4.10B), while Tempus AI trades at $70.93 (market cap $12.58B). The key difference: Tempus AI is far larger — about 3.1× First Trust NASDAQ 100 Technology Index Fund's market cap, and First Trust NASDAQ 100 Technology Index Fund is trading nearer its 52-week high, Tempus AI nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold First Trust NASDAQ 100 Technology Index Fund for 40 Days and Tempus AI for 23 Days on average.
| QTEC | TEM | |
|---|---|---|
Market Cap | $4.10B | $12.58B |
Volume | 264,303 | 7,444,569 |
Sector | Broad Market / Factor | Broad Market / Factor |
52-Week High | $340.28 | $99.28 |
52-Week Low | $207.03 | $41.55 |
Typical Hold Time | 40 Days | 23 Days |
Enterprise Value | — | $13.21B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
QTEC trades at $331.55, down 1.27% today, with a bullish technical signal from moving averages but neutral oscillators. The ETF provides equal-weighted exposure to NASDAQ-100 technology stocks, though key valuation and profitability ratios are unavailable in the provided data. Recent analysis highlights the software sector's undervaluation relative to historical averages, positioning QTEC as a liquid alternative to similar tech ETFs.
The outlook remains cautiously optimistic given the ETF's broad tech exposure and bullish technical trend, but risks include sector volatility and macroeconomic pressures. Investors should weigh the ETF's diversification benefits against potential headwinds in the technology sector.
Tempus AI (TEM) trades at $70.93, up 0.91% today, with a bullish technical signal and strong analyst support. The stock shows robust revenue growth, with 2026 revenue reaching $1.4B, but remains unprofitable with a net margin of -17.77%. Recent FDA clearance for its ECG-MR AI product and positive ESMO Congress abstracts highlight innovation momentum, though negative cash flow from operations and insider selling pose concerns.
Outlook is cautiously optimistic given 64% buy ratings and a $72.60 consensus target, but profitability challenges and high valuation multiples (P/S 8.61, P/B 28.27) demand scrutiny. Key risks include sustained losses, competitive pressures, and reliance on financing activities for liquidity.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About First Trust NASDAQ 100 Technology Index Fund
QTEC is an ETF that seeks to track the performance of the NASDAQ-100 Technology Sector Index. The fund provides targeted exposure to companies within the NASDAQ-100 that are classified as technology or telecommunications companies, focusing on firms involved in software, hardware, and related services. QTEC is a tool for investors seeking focused exposure to high-growth, large-cap technology companies listed on the NASDAQ exchange.
Read more on QTEC →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
